Recurrent Ovarian Germ Cell Tumor Completed Phase 1 Trials for Temsirolimus (DB06287)

IndicationStatusPhase
DBCOND0029793 (Recurrent Ovarian Germ Cell Tumor)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00408655Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid TumorsTreatment
NCT01155258Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsTreatment